Is the active ingredient.
Chronic stable angina pectoris (chest pain) in patients with a heart rate above 70 bpm who are inadequately controlled with betablockers or intolerant to them.
Chronic heart failure (reduced ejection fraction) in patients with a heart rate above 70 bpm who tolerate betablockers but have symptoms despite optimal beta-blocker therapy
Ivabrad 7.5mg Tab (Ivabradine) selectively inhibits the If current in the sinoatrial node, reducing the heart rate. This leads to a decrease in myocardial oxygen demand, thereby relieving angina symptoms and improving symptoms in chronic heart failure.
Store at room temperature (below 25°C/77°F), away from moisture and light. Keep out of reach of children.
Dosage and frequency should be determined by a physician. It's typically started at a low dose and gradually increased.
Common dosages range from 5 mg to 7.5 mg twice daily but may vary based on individual needs and response.
Always follow your physician's instructions exactly.
Bradycardia (slow heart rate)
Atrial fibrillation (irregular heartbeat)
Dizziness
Headache
Blurred vision (phosphenes)
Hypertension
Nausea
Constipation
Alcohol may enhance the risk of side effects. Consult your physician about alcohol consumption while taking Ivabradine.
Ivabradine may cause dizziness or blurred vision. Avoid driving or operating machinery until you know how this medication affects you.
The use of Ivabradine during pregnancy and breastfeeding is generally not recommended. Consult your physician to discuss the risks and benefits.
Ivabradine is not recommended for use in children.
Dosage adjustment may be needed in patients with severe kidney impairment. Consult your physician.
Dosage adjustment may be needed in patients with severe liver impairment. Consult your physician.
Please consult your doctor or pharmacist for detailed information and references to clinical studies.
